Borvo Medical

Borvo Medical is a private, commercial-stage medical device company targeting the growing market for chronic subdural hematoma (cSDH) treatment. Its core innovation is the FDA-cleared Borvo EVAC™ system, which leverages advanced 3D-printed titanium fabrication and ergonomic design to offer a more efficient, less invasive tool for hematoma evacuation, often used in conjunction with middle meningeal artery (MMA) embolization. Early clinical data from five medical centers shows a 100% success rate in initial cases, positioning the company to capitalize on the rapid adoption of MMA procedures. The company is led by experienced medtech entrepreneurs and is backed by a specialized venture firm.

Advanced 3D-printed non-ferromagnetic titanium fabrication platform for creating ergonomic, high-lumen cranial access and drainage devices for minimally invasive neurosurgery.

Borvo competes against traditional burr hole ports, drainage catheters, and manual evacuation techniques used in SDH surgery. It faces potential competition from large, integrated neurovascular device companies (e.g., Stryker, Medtronic, Johnson & Johnson) that could develop similar products and leverage existing strong hospital relationships.